Impact of molecular profiling on survival in patients with advanced biliary tract cancers

被引：1
|
作者：
Antoun, L. [1 ]
Deneche, I. [1 ]
Boileve, A. [2 ]
Tarabay, A. [2 ]
Rouleau, E. [1 ]
El Rawadi, E. [1 ]
Eid, R. [1 ]
Lacroix, L. [1 ]
Valery, M. [1 ]
Boige, V. [1 ]
Dartigues, P. [1 ]
Bani, M. [1 ]
Smolenschi, C. [2 ]
Scoazec, J. [1 ]
Ducreux, M. [1 ]
Hollebecque, A. [2 ]
Malka, D. [3 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Mutualiste Montsouris, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SO-4
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [41] Biliary tract cancers: systemic therapy for advanced disease
    Martinez, Francisco J.
    Shroff, Rachna T.
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (01)
  • [42] Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
    Kang, Sandra
    El-Rayes, Bassel F.
    Akce, Mehmet
    CANCERS, 2022, 14 (07)
  • [43] Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
    Apurva Jain
    Lawrence N Kwong
    Milind Javle
    Current Treatment Options in Oncology, 2016, 17
  • [44] Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
    Jain, Apurva
    Kwong, Lawrence N.
    Javle, Milind
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (11)
  • [45] Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
    Ikeda, Masafumi
    Ioka, Tatsuya
    Fukutomi, Akira
    Morizane, Chigusa
    Kasuga, Akiyoshi
    Takahashi, Hideaki
    Todaka, Akiko
    Okusaka, Takuji
    Creasy, Caretha L.
    Gorman, Shelby
    Felitsky, Daniel J.
    Kobayashi, Mikiro
    Zhang, Fanghong
    Furuse, Junji
    CANCER SCIENCE, 2018, 109 (01): : 215 - 224
  • [46] A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
    Kim, Richard D.
    Kim, Dae Won
    Alese, Olatunji B.
    Li, Daneng
    Shah, Neal
    Schell, Michael J.
    Zhou, Jun Min
    Chung, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
    Jonathan D Mizrahi
    Valerie Gunchick
    Kabir Mody
    Lianchun Xiao
    Phanikeerthi Surapaneni
    Rachna T Shroff
    Vaibhav Sahai
    World Journal of Gastrointestinal Oncology, 2020, (01) : 83 - 91
  • [48] A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers
    Den Linger, Crystal S.
    Meropol, Neal J.
    Li, Tianyu
    Lewis, Nancy L.
    Engstrom, Paul F.
    Weiner, Louis M.
    Cheng, Jonathan D.
    Alpaugh, R. Katherine
    Cooper, Harry
    Wright, John J.
    Cohen, Steven J.
    CLINICAL COLORECTAL CANCER, 2014, 13 (02) : 81 - 86
  • [49] Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
    Mizrahi, Jonathan D.
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phanikeerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (01) : 83 - 91
  • [50] The clinical impact of c-MET over-expression in advanced biliary tract cancers
    Heo, Mi Hwa
    Kim, Seung Tae
    Park, Young Suk
    Park, Joon Oh
    Lee, Hansang
    CANCER RESEARCH, 2017, 77
12345